Ligand Pharmaceuticals reported $57.89M in Operating Expenses for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Expenses Change
Acorda Therapeutics ACOR:US $ 44.97M 5.73M
Agenus AGEN:US $ 65.49M 4.09M
Amgen AMGN:US $ 4.42B 680M
Anika Therapeutics ANIK:US $ 43.04M 2.79M
Arrowhead Research ARWR:US $ 105.32M 4.93M
Baxter International BAX:US $ 3395M 149M
Bristol Myers Squibb BMY:US $ 9.3B 202M
Clovis Oncology CLVS:US $ 91.52M 6.92M
Eli Lilly And LLY:US $ 5277.9M 127.8M
Enanta Pharmaceuticals ENTA:US $ 52.02M 544K
Gilead Sciences GILD:US $ 4231M 2162M
Glaxosmithkline GSK:US 5.85B 1.13B
GlaxoSmithKline GSK:LN 584.8B 95.1B
Harsco HSC:US $ 575.91M 130.32M
Heron Therapeutics HRTX:US $ 77.13M 9.25M
Immunogen IMGN:US $ 75.22M 14.28M
Insmed INSM:US $ 153.54M 10.6M
Intrexon XON:US $ 27.07M 22.84M
Karyopharm Therapeutics KPTI:US $ 82.59M 331K
Lannett LCI:US $ 152.15M 51.71M
Ligand Pharmaceuticals LGND:US $ 57.89M 4.39M
Macrogenics MGNX:US $ 67.82M 9.92M
Merk MRK:US $ 9666M 666M
Pacira Pharmaceuticals PCRX:US $ 138.18M 2.42M
Pfizer PFE:US $ 15640M 148M
Rigel Pharmaceuticals RIGL:US $ 42.78M 212K
Sangamo Biosciences SGMO:US $ 75.11M 1.62M
Spectrum Pharmaceuticals SPPI:US $ 25.39M 11.33M
Teva Pharmaceutical Industries TEVA:US 4.74B 361M
Veracyte VCYT:US $ 83.6M 566K